JPRN-jRCTs031200235
Recruiting
Phase 2
An open-label randomized controlled trial to evaluate post-operative ulcer healing with cholestyramine under PPIs in patients with early gastric cancer ESD
Tamura Shigeki0 sites100 target enrollmentDecember 9, 2020
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tamura Shigeki
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Patients between the ages of 20 and 85 years old at the time of obtaining consent.
- •2\) Patients with early stage gastric cancer or gastric adenoma who are eligible for ESD
- •3\) Patients with written consent from the individual to participate in this study.
Exclusion Criteria
- •1\) Patients with two or more gastric lesions to be resected in pieces in a single treatment (excluding en bloc resection).
- •2\) Patients with psychosis, alcoholism, drug addiction, or drug addiction that may affect compliance with the research protocol.
- •3\) Patients who are breastfeeding or who may be pregnant
- •4\) Patients with biliary atresia or hypersensitivity
- •5\) Patients with intestinal obstruction and the cause of the obstruction is not yet known or treated.
- •6\) Patients on oral statins
- •7\) Patients taking cholestyramine or cholestimide
- •8\) Other patients who are judged by the principal investigator to be unsuitable as subjects for this study.
- •9\) Patients who are taking NSAIDs on time
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
To study the effect of Bhunimbadi Vati and its add-on effect with Tablet Glimepiride Metformin in Madhumeha wsr to Type 2 Diabetes mellitusHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2023/03/050496Dr Kiran Damoo Ubhe
Completed
Not Applicable
An open-label randomized controlled trial to assess the efficacy and safety of chronic hepatitis C and compensated cirrhosis patients with the prescribing pattern of vitaminD plus peginterferon alpha-2a /ribavirin.Chronic hepatitisC patients and compensated cirrhosis patientsJPRN-UMIN000008342Saitama Medical University80
Completed
Not Applicable
An open-label randomized controlled trial to assess the efficacy and safety of chronic hepatitis C patients with vitaminD plus peginterferon alpha-2a /ribavirin.versus alfacalcidol plus peginterferon alpha-2a /ribavirin.Chronic hepatitis C patients with genotype 1 and high viral load (>= 5 Log IU/mL)JPRN-UMIN000004210Saitama Medical University40
Not yet recruiting
Not Applicable
A trial to assess the role of serial physical examination for well appearing babies at risk of sepsisCTRI/2024/04/066566ONE
Not yet recruiting
Phase 3
Effect of Dapagliflozin on Unconscious functions of the heart in Diabetic Patients.Health Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2024/04/065339Krishna Keerthi Annepu